Spirox, a company based in Menlo Park, California, won FDA clearance for its LATERA nasal implant. It’s designed to support the upper and lower lateral nasal cartilages in patients suffering from nasal valve collapse that causes obstructions and difficulty breathing. Eventually absorbed by the body after about 18 months, it’s expected to restore the natural strength of the nasal cavity.
